Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control

Producción Científica

Detalles Bibliográficos
Autores: Herrero Sánchez, María del Carmen, Rodríguez Serrano, Concepción, Almeida Parra, Julia, San Segundo Payo, Laura, Inogés Sancho, Laura, Santos-Briz Terrón, Ángel, García Briñón, Jesús, San Miguel Izquierdo, Jesús F., Cañizo Fernández-Roldán, Consuelo del, Blanco Durango, Belén
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Universidad de Valladolid
Repositorio:UVaDOC. Repositorio Documental de la Universidad de Valladolid
OAI Identifier:oai:uvadoc.uva.es:10324/55160
Acceso en línea:https://doi.org/10.1111/bjh.13984
https://uvadoc.uva.es/handle/10324/55160
Access Level:acceso abierto
Palabra clave:Graft versus host disease
Cell transplantation
Trasplante de células
Pharmacology
MTOR inhibitors
3205.04 Hematología
3201.01 Oncología
id ES_b997ce16e4f2ad2d55bf9c02b439733a
oai_identifier_str oai:uvadoc.uva.es:10324/55160
network_acronym_str ES
network_name_str España
repository_id_str
spelling Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease controlHerrero Sánchez, María del CarmenRodríguez Serrano, ConcepciónAlmeida Parra, JuliaSan Segundo Payo, LauraInogés Sancho, LauraSantos-Briz Terrón, ÁngelGarcía Briñón, JesúsSan Miguel Izquierdo, Jesús F.Cañizo Fernández-Roldán, Consuelo delBlanco Durango, BelénGraft versus host diseaseCell transplantationTrasplante de célulasPharmacologyMTOR inhibitors3205.04 Hematología3201.01 OncologíaProducción CientíficaThe mechanistic target of rapamycin (mTOR) pathway is crucial for the activation and function of T cells, which play an essential role in the development of graft-versus-host disease (GvHD). Despite its partial ability to block mTOR pathway, the mTORC1 inhibitor rapamycin has shown encouraging results in the control of GvHD. Therefore, we considered that simultaneous targeting of both mTORC1 and mTORC2 complexes could exert a more potent inhibition of T cell activation and, thus, could have utility in GvHD control. To assess this assumption, we have used the dual mTORC1/mTORC2 inhibitors CC214-1 and CC214-2. In vitro studies confirmed the superior ability of CC214-1 versus rapamycin to block mTORC1 and mTORC2 activity and to reduce T cell proliferation. Both drugs induced a similar decrease in Th1/Th2 cytokine secretion, but CC214-1 was more efficient in inhibiting na€ıve T cell activation and the expression of Tcell activation markers. In addition, CC214-1 induced specific tolerance against alloantigens, while preserving anti-cytomegalovirus response. Finally, in a mouse model of GvHD, the administration of CC214-2 significantly improved mice survival and decreased GvHD-induced damages. In conclusion, the current study shows, for the first time, the immunosuppressive ability of CC214-1 on T lymphocytes and illustrates the role of CC214-2 in the allogeneic transplantation setting as a possible GvHD prophylaxis agent.Gerencia Regional de Salud de Castilla y León (Proyecto GRS 726/A13)John Wiley & Sons2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://doi.org/10.1111/bjh.13984https://uvadoc.uva.es/handle/10324/55160reponame:UVaDOC. Repositorio Documental de la Universidad de Valladolidinstname:Universidad de ValladolidIngléshttps://onlinelibrary.wiley.com/doi/10.1111/bjh.13984info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/4.0/oai:uvadoc.uva.es:10324/551602026-06-13T12:44:47Z
dc.title.none.fl_str_mv Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control
title Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control
spellingShingle Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control
Herrero Sánchez, María del Carmen
Graft versus host disease
Cell transplantation
Trasplante de células
Pharmacology
MTOR inhibitors
3205.04 Hematología
3201.01 Oncología
title_short Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control
title_full Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control
title_fullStr Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control
title_full_unstemmed Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control
title_sort Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control
dc.creator.none.fl_str_mv Herrero Sánchez, María del Carmen
Rodríguez Serrano, Concepción
Almeida Parra, Julia
San Segundo Payo, Laura
Inogés Sancho, Laura
Santos-Briz Terrón, Ángel
García Briñón, Jesús
San Miguel Izquierdo, Jesús F.
Cañizo Fernández-Roldán, Consuelo del
Blanco Durango, Belén
author Herrero Sánchez, María del Carmen
author_facet Herrero Sánchez, María del Carmen
Rodríguez Serrano, Concepción
Almeida Parra, Julia
San Segundo Payo, Laura
Inogés Sancho, Laura
Santos-Briz Terrón, Ángel
García Briñón, Jesús
San Miguel Izquierdo, Jesús F.
Cañizo Fernández-Roldán, Consuelo del
Blanco Durango, Belén
author_role author
author2 Rodríguez Serrano, Concepción
Almeida Parra, Julia
San Segundo Payo, Laura
Inogés Sancho, Laura
Santos-Briz Terrón, Ángel
García Briñón, Jesús
San Miguel Izquierdo, Jesús F.
Cañizo Fernández-Roldán, Consuelo del
Blanco Durango, Belén
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Graft versus host disease
Cell transplantation
Trasplante de células
Pharmacology
MTOR inhibitors
3205.04 Hematología
3201.01 Oncología
topic Graft versus host disease
Cell transplantation
Trasplante de células
Pharmacology
MTOR inhibitors
3205.04 Hematología
3201.01 Oncología
description Producción Científica
publishDate 2016
dc.date.none.fl_str_mv 2016
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.1111/bjh.13984
https://uvadoc.uva.es/handle/10324/55160
url https://doi.org/10.1111/bjh.13984
https://uvadoc.uva.es/handle/10324/55160
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv https://onlinelibrary.wiley.com/doi/10.1111/bjh.13984
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv John Wiley & Sons
publisher.none.fl_str_mv John Wiley & Sons
dc.source.none.fl_str_mv reponame:UVaDOC. Repositorio Documental de la Universidad de Valladolid
instname:Universidad de Valladolid
instname_str Universidad de Valladolid
reponame_str UVaDOC. Repositorio Documental de la Universidad de Valladolid
collection UVaDOC. Repositorio Documental de la Universidad de Valladolid
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417786051133440
score 15,300719